These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3853964)
1. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus. Meyers BR; Srulevitch ES; Hirschman SZ Antimicrob Agents Chemother; 1985 Nov; 28(5):706-7. PubMed ID: 3853964 [TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents. Thomas MG; Lang SD J Antimicrob Chemother; 1986 Aug; 18(2):171-5. PubMed ID: 3639086 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Aldridge KE; Janney A; Sanders CV Antimicrob Agents Chemother; 1985 Nov; 28(5):634-8. PubMed ID: 2936300 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus. Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis. Van der Auwera P; Klastersky J Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice. Hirschl AM; Georgopoulos A; Stanek G; Breyer S; Rotter ML Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157 [TBL] [Abstract][Full Text] [Related]
7. Activity of coumermycin against clinical isolates of staphylococci. Guillemin MN; Miles HM; McDonald MI Antimicrob Agents Chemother; 1986 Apr; 29(4):608-10. PubMed ID: 3707109 [TBL] [Abstract][Full Text] [Related]
8. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs. Traub WH; Spohr M; Bauer D Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks. Jones RN; Barry AL Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of coumermycin alone and in combination with other antibiotics. Neu HC; Chin NX; Labthavikul P Antimicrob Agents Chemother; 1984 Jun; 25(6):687-9. PubMed ID: 6331295 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Elwell LP; Wilson HR; Knick VB; Keith BR Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents. Ishag AJ; Durgham SM; Shibl AM Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333 [TBL] [Abstract][Full Text] [Related]
14. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Guenthner SH; Wenzel RP Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606 [TBL] [Abstract][Full Text] [Related]
15. In vitro studies of the activity of coumermycin-A1 against staphylococci resistant to methicillin and cephalothin. Michaeli D; Meyers B; Weinstein L J Infect Dis; 1969 Oct; 120(4):488-90. PubMed ID: 5195766 [No Abstract] [Full Text] [Related]
16. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus. Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination. Perronne CM; Malinverni R; Glauser MP Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060 [TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus. Van der Auwera P; Joly P J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884 [TBL] [Abstract][Full Text] [Related]
19. Synergism of coumarins from the Chinese drug Zanthoxylum nitidum with antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). Zuo GY; Wang CJ; Han J; Li YQ; Wang GC Phytomedicine; 2016 Dec; 23(14):1814-1820. PubMed ID: 27912884 [TBL] [Abstract][Full Text] [Related]
20. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]